CCL2 and breast cancer: In TNBC, TGF-β, CXCR2, and c-MET/HGF axes dominate TAN recruitment and immunosuppressive polarization, whereas in HR+ BC, TGF-β, IL-6, CCL2, and estrogen signaling help shape a similarly suppressive TME [61].